Management of tumor volume changes during preoperative radiotherapy for extremity soft tissue sarcoma: a new strategy of adaptive radiotherapy
Abstract
Purpose: Using adaptive radiotherapy (ART), determine objective clinical criteria that identify extremity soft tissue sarcoma (ESTS) patients requiring adaptation of their preoperative radiotherapy (RT) plan.
Methods: We collected clinical, tumor parameter and treatment data from 17 patients with a lower extremity ESTS treated with RT, using helicoidal intensity-modulated RT (IMRT) tomotherapy, before surgical resection, between 2019 and 2021. Repositioning was ascertained by daily MV-CT (megavoltage computed tomography) imaging. Using the PreciseART technology we retrospectively manually delineated at least one MV-CT for each patient per week and recorded volume and dosimetric parameters. A greater than 5% change between target volume and planned target volume (PTV) dosimetric coverage from the initial planning CT scan to at least one MV-CT was defined as clinically significant.
Results: All 17 patients experienced significant tumor volume changes during treatment; 7 tumors grew (41%) and 10 shrank (59%). Three patients (18%), all undifferentiated pleomorphic sarcomas with increased volume changes, experienced significant reductions in tumor dose coverage. Seven patients required a plan adaptation, as determined by practical criteria applied in our departmental practice. Among these patients, only one ultimately experienced a significant change in PTV coverage. None of the patients with decreased tumor volumes had reduced target volume coverage. Monitoring volume variations by estimating GTV (gross tumor volume) on MV-CT, in addition to axial and sagittal linear tumor dimensions, appeared to be most effective for detecting reductions in PTV coverage throughout treatment.
Conclusions: Variations in ESTS volume are evident during preoperative RT, but significant dosimetric variations are rare. Specific attention should be paid to grade 2-3 UPSs during the first 2 weeks of treatment. In the absence of dedicated software in routine clinical practice, monitoring of tumor volume changes by estimating GTV may represent a useful strategy for identifying patients whose treatment needs to be replanned.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Anne Ducassou, Marion Geneau de Lamarlière, Amélie Lusque, Justine Attal-Khalifa, Vincent Esteyrie, Christine Chevreau, Thibaud Valentin, Dimitri Gangloff, Thomas Meresse, Louis Courtot, Philippe Rochaix, Bérénice Boulet, Eliane Graulière
This work is licensed under a Creative Commons Attribution 4.0 International License.
License to Publish
Please read the terms of this agreement, print, initial page 1, sign page 3, scan and send the document as one file attached to an e-mail to gsersa@onko-i.si